The non-steroidal anti-inflammatory drugs (NSAIDs) are a widely used group of drugs in clinical medicine. However, their propensity to cause gastrointestinal damage limits their clinical utility. The pathogenesis of this toxicity is not well established. It has been postulated that an early event in the development of damage is an effect of these drugs on mitochondrial function. The present paper sets out to evaluate the effects of indomethacin, a commonly used NSAID, on energy metabolism in vivo. Indomethacin was administered to male Sprague-Dawley rats, either intrajejunally or orally, and indices of mitochondrial function were determined. The parameters chosen for this purpose were oxygen uptake by, lactate levels in and the energy charge of jejunal tissue. Oxygen uptake by and energy charge in jejunal tissue were unaffected at 1 and 3 h after dosing by gavage with indomethacin. The drug significantly affected the tissue lactate/pyruvate ratio at 3 h (but not at 1 h) after oral dosing. Effects of indomethacin on jejunum incubated ex vivo were found to be reversible. The data suggest that indomethacin affects mitochondrial function in vivo, but that compensatory changes in glycolytic rate maintain energy charge.
INTRODUCTION
The non-steroidal anti-inflammatory drugs (NSAIDs) are used extensively in clinical medicine. However, they show a propensity to cause gastrointestinal ulceration and subsequent bleeding [1, 2] . NSAIDs also cause an enteropathy, but the pathogenesis of this damage is controversial. NSAIDs are known to inhibit cyclooxygenase, but this does not fully explain the mechanism of damage, as it is possible to inhibit gastric cyclooxygenase almost completely without apparent damage [3] . It is also known that several NSAIDs, such as aspirin and indomethacin, act as uncouplers of mitochondrial oxidative phosphorylation [4] . Studies with these drugs in isolated mitochondrial preparations have shown that they uncouple oxidative phosphorylation at low concentrations and inhibit it at higher concentrations [5] [6] [7] . In addition, indomethacin has been shown to inhibit oxidative phosphorylation at high concentrations in jejunal tissue in vitro [8] . Evidence for mitochondrial damage in vivo has also been found, but this has been limited to morphological studies [6] .
The present study was therefore undertaken in an attempt to determine whether the effects of indomethacin on rat jejunal tissue ex vivo and in vivo are similar to those suggested from in vitro studies [8] , and to investigate the possible functional consequences, namely whether indomethacin leads to changes in ATP level\ energy charge in vivo.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats, 200-250 g body weight were obtained from Charles River UK Ltd, and used as the source of rat jejunal tissue. The rats were anaesthetized using an anaesthetic cocktail consisting of Hypnovel (midazolam hydrochloride 5 mg\ml ; Roche) and Hypnorm (fentanyl citrate 0n315 mg\ml and fluanisone 10 mg\ml ; Janssen). Indomethacin (Sigma Chemical Co.) was the NSAID studied. 2,4-Dinitrophenol (DNP) (BDH Chemicals), a classical uncoupler of oxidative phosphorylation, was used for purposes of comparison. Both drugs were suspended in DMSO, with the final concentration of the vehicle being 10 % (v\v). All procedures on animals were undertaken according to the requirements laid down by the U.K. Home Office.
Determination of the effects of indomethacin on oxygen uptake and lactate production by rat jejunum ex vivo Rats were fasted overnight. The next morning, they were dosed by oral gavage with indomethacin at 20 mg\kg or an equal volume of vehicle. This dose of indomethacin is high compared with the therapeutic dose in humans, but is a commonly used dose in intestinal toxicity studies in the rat. After 1 h, the rats were anaesthetized using the anaesthetic cocktail. A segment of mid-jejunum was removed, weighed (30-50 mg) and incubated at 37 mC in a Clarke's oxygen electrode to measure oxygen uptake by the tissue. The buffer used in the incubation was : 125 mM NaCl, 3n5 mM KCl, 16 mM Hepes, 10 mM MgCl # , 1 mM CaCl # , 10 mM glucose, pH 7.4. The amount of lactate released into the incubation medium by the tissue was measured as follows : 100 µl of the buffer was sampled at the end of the incubation period and assayed for lactate according to the spectrophotometric method of Beutler [9] .
The experiment was repeated in another group of rats, from which jejunal tissue was obtained in the same fashion as described above, but 3 h after the oral dose of indomethacin or vehicle.
Determination of the effects of indomethacin and DNP on energy charge in rat jejunum in vivo
The drug was administered either intrajejunally or by gavage after an overnight fast. Intrajejunal injection was performed on rats anaesthetized using the anaesthetic cocktail. A laparotomy was performed and a loop of jejunum, 10 cm distal to the ligament of Treitz, was exposed. Indomethacin or DNP in 1 ml, or an equal volume of vehicle (10 % DMSO), was injected into the jejunal lumen and left for 0n5, 5 or 60 min. Care was taken to see that the injected fluid did not flow proximally. The site of the injection was marked with a loose suture. At the end of the period, the luminal contents were flushed out without overdistending the jejunal loop, and tissue 5 cm distal to the site of injection was freeze-clamped. The flattened segment of tissue within the clamp was ground up in liquid nitrogen and thawed in 10 % (v\v) perchloric acid. The resultant perchloric acid extract was centrifuged at 4 mC and neutralized with 3 M potassium carbonate, using 0n05 % Methyl Orange as indicator. This extract was used for the determination of energy charge as described below.
In a separate series of experiments, rats were dosed orally with indomethacin (20 mg\kg) in 10 % (v\v) DMSO. Control animals received an equal volume of 10 % (v\v) DMSO. At 1 or 3 h later, the animals were anaesthetized using the anaesthetic cocktail. A laparotomy was then performed and jejunal tissue, approx. 15 cm distal to the ligament of Treitz, was isolated. This segment was freeze-clamped in vivo and used for assay of the adenine nucleotides and determination of the energy charge, as described above.
Determination of energy charge and lactate/pyruvate ratio
Lactate and pyruvate levels were measured in the neutralized extract according to the spectrophotometric method of Beutler [9] . Lactate\pyruvate ratios were then calculated. The neutralized extract obtained as detailed above was used in assays for the three adenine nucleotides, ATP, ADP and AMP, according to the spectrophotometric method of Beutler [9] , and the energy charge [10] for each sample was calculated using the formula :
Determination of the effect of preincubation with indomethacin on oxygen uptake by rat jejunum in vitro
In order to determine whether the inhibitory effect of indomethacin on oxygen uptake by rat jejunum is reversible or irreversible, jejunal tissue was obtained from an anaesthetized rat and the baseline oxygen uptake was measured in the oxygen electrode, using Hepes buffer, pH 7n4, as described above. After this, the fragment was removed and incubated in buffer containing 2n5 mM indomethacin for 5 min. At the end of this period, the tissue was removed, rinsed briefly in fresh buffer and then returned to the oxygen electrode to measure oxygen uptake. The rate of uptake after incubation with the drug was compared with the rate before incubation. Control measurements were also carried out, as described above, with 10 % (v\v) DMSO substituted for the drug.
Statistics
Student's t test was used for statistical analysis of the data obtained. A P value of 0n05 was considered significant.
RESULTS
No significant effects of orally administered indomethacin were seen on oxygen uptake or lactate pro-Effects of indomethacin on rat jejunum in vivo Table 1 Effects of indomethacin on oxygen uptake and lactate production by rat jejunum ex vivo Rats were dosed orally with equal volumes of either control solution (10 % DMSO) or one containing indomethacin (20 mg/kg) after an overnight fast. They were then allowed free access to food and water. After 1 or 3 h, a fragment of jejunum was removed from each animal, under anaesthesia, and used for measurement of oxygen uptake and lactate production. Data are means (S.E.M.) for n l 6 rats in each group. Table 2 Oxygen uptake byrat jejunum in vitro after preincubationwith 2;5 mM indomethacin Oxygen uptake by rat jejunal fragments was measured before and after incubation in 2n5 mM indomethacin or control solution (10 % DMSO). Data are means (S.E.M.) ; n l 6.
Treatment
Oxygen uptake at baseline (nmol:min
Oxygen uptake after treatment Animals were anaesthetized, then segments of jejunum, 15 cm distal to the ligament of Treitz and 5 cm distal to site of intrajejunal injection, were freezeclamped at 0n5, 5 and 60 min after intrajejunal injection of indomethacin or control solution. Energy charge was determined in these segments. Data are means (S.E.M.) ; n l 6. Significance of differences : *P 0n05, **P 0n01 when energy charge at 60 min was compared with that at 0n5 min, using Student's t test.
Energy charge 0n5 min 5 min 60 min Control 0n88 (0n02) 0n79 (0n04) 0n77 (0n02)** Indomethacin (20 mg/kg) 0n87 (0n02) 0n83 (0n02) 0n79 (0n03)* duction by jejunal tissue ex vivo 1 and 3 h after the oral dose of the drug (Table 1) . Preincubation of tissue in 2n5 mM indomethacin did not significantly affect oxygen uptake by the tissue when compared with tissue that had been preincubated with vehicle (Table 2 ). This was in contrast with results obtained when oxygen uptake by jejunal tissue in vitro was measured in the presence of 2n5 mM indomethacin. In this case there was a significant fall in oxygen uptake, i.e. 1n32 (p0n09) nmol:min −" :mg −" in the presence of the drug, compared with a control value of 1n82 (p0n21) nmol:min −" :mg −" . The effect of intrajejunally administered indomethacin (20 mg\kg) on the energy charge of the jejunum was Table 4 Effects of indomethacin and DNP on energy charge and lactate/pyruvate ratio in vivo, 5 min after intrajejunal injection of the drug Segments of jejunum, 15 cm distal to the ligament of Treitz and 5 cm distal to site of intrajejunal injection, were freeze-clamped at 5 min after intrajejunal injection of indomethacin, DNP or control solution. These segments were used for the determination of energy charge and lactate/pyruvate ratio. Data are means (S.E.M.) ; n l 6. Significance of difference : *P 0n05 compared with control, using Student's t test.
Energy charge Lactate/pyruvate ratio
determined at various time intervals after injection. As shown in Table 3 , there were no significant differences between the control and indomethacin-treated groups. However, within the control or drug-treated groups themselves, the energy charge measured at 60 min was significantly lower than that at 0n5 min. Table 4 shows the data obtained 5 min after intrajejunal injection of various concentrations of indomethacin or DNP. None of the indomethacin solutions had any significant effect on the energy charge of the tissue. DNP did, however, decrease the energy charge in the tissue to a significant extent. Neither indomethacin nor DNP affected lactate\pyruvate ratios in the tissue significantly. Table 5 Effects of indomethacin (20 mg/kg) on energy charge and lactate/pyruvate ratio in rat jejunum in vivo, 1 h and 3 h after oral administration of the drug Rats were dosed with indomethacin (20 mg/kg) orally. After 1 or 3 h, the animals were anaesthetized, and a segment of jejunum 15 cm distal to the ligament of Treitz was freeze-clamped and used for the determination of energy charge and lactate/pyruvate ratio. Data are means (S.E.M.) ; n l 6. Significance of difference : *P 0n05 compared with control, using Student's t test.
Treatment Energy charge
Lactate/pyruvate ratio 1 h after dose 3 h after dose 1 h after dose 3 h after dose
The energy charge of the tissue was unaffected at both 1 and 3 h after an oral dose of indomethacin ( Table 5 ). The lactate\pyruvate ratio was unchanged at 1 h, but was raised significantly at 3 h.
DISCUSSION
Ultrastructural damage suggestive of uncoupling of intestinal mitochondria has been shown to occur as early as 1 h after an oral dose of indomethacin, with more severe changes evident 3 h after oral dosing [6] . The rationale behind choosing to measure the various parameters of energy metabolism, i.e. oxygen uptake, lactate production and energy charge, at 1 and 3 h after the administration of the drug was to allow a direct comparison with previous studies. Like most other NSAIDs, indomethacin undergoes an enterohepatic circulation, which may be relevant for the 3 h data. The concentrations of indomethacin present in jejunal cells in vivo 1 and 3 h after an oral dose are not known with certainty. Weissenborn et al. [11] showed that, 1 h after an oral dose of indomethacin (10 mg\kg), the concentration of the drug in the jejunal mucosa was approx. 0n01 mM, while the level after 3 h was approx. 0n02 mM. In the present study, the oral dose of indomethacin used was 20 mg\kg. Based on the data of Weissenborn et al. [11] , which do not take into account the possible subcellular compartmentalization of drug distribution, this dose of drug would result in concentrations well below those shown to produce uncoupling or inhibition in mitochondrial preparations and in tissue in vitro [5] [6] [7] . This appears to be borne out by the observations that no significant effects of the drug were demonstrable on the mitochondrial parameters measured after the oral dose (Tables 1 and 5 ). The only indication that energy metabolism in the tissue may have been affected lay in the finding that the lactate\pyruvate ratio was significantly higher in the indomethacin-treated tissue compared with control tissue, indicating an accelerated rate of glycolysis (Table 5) .
Another possibility that might explain a lack of demonstrable effects is that the effects of indomethacin may be reversible, and hence it may not be possible to detect any in vivo changes in the tissue using ex vivo measurements. In order to test this hypothesis, jejunal tissue obtained from an anaesthetized rat was preincubated for 5 min with indomethacin at a concentration of 2n5 mM, which is known to be inhibitory [8] , after measurement of its baseline rate of oxygen uptake. The tissue was then transferred back to the oxygen electrode to measure its rate of oxygen uptake again, in indomethacin-free medium. There was no significant difference between the rates of uptake by tissue that had been incubated in 2n5 mM indomethacin and that which had been incubated in control solution (Table 2) . This seems to indicate that the inhibition produced by 2n5 mM indomethacin is reversible. Once the tissue is transferred out of the indomethacin solution into incubation buffer, the drug within the tissue probably diffuses out of the cells into the medium, and the levels within the enterocytes would then no longer be high enough to sustain any effect that may have occurred. The reversible nature of the inhibition produced by indomethacin in jejunal tissue in vitro could also account for the findings that no effects of the drug were demonstrable on oxygen uptake and lactate production measured ex vivo 1 and 3 h after the oral dose (Table 1) .
The findings in Table 3 show that the energy charge of tissue treated with indomethacin for various time intervals in vivo did not differ significantly from corresponding control values. Within the drug-treated or control group, however, the energy charge value at 60 min after intrajejunal injection of indomethacin or vehicle was significantly lower than the values at 0n5 min after the drug or vehicle respectively. This suggests that increasing the duration of exposure to the anaesthetic appears to affect energy metabolism in the experimental animal in vivo. Other workers have also documented this finding [12, 13] . The possible reasons for such a scenario include changes in intestinal blood flow [14] and alterations in mucosal integrity and cellular energy levels [15] . Thus determinations of parameters of energy metabolism in vivo, if done under the influence of anaesthesia (as they invariably are), might tend to give underestimates of the true values. This poses particular problems for the interpretion of such data. Under these circumstances, small falls in energy charge (as are likely to be produced by indomethacin) may not be detectable. This may account for the finding that changes in energy charge in vivo were not demonstrable in indomethacin-treated rats.
Similar concentrations of indomethacin that were used for in vitro incubations [8] , i.e. 0n1, 0n5 and 2n5 mM, were next injected intrajejunally to make direct comparisons of effects in vitro and in vivo. There was no demonstrable effect of indomethacin on energy charge in this instance either (Table 4) . Reasons similar to those outlined above may account for these findings. It is noteworthy, however, that DNP had a detectable effect, presumably reflecting the greater uncoupling potency of DNP as compared with indomethacin [7] .
These observations show that it is difficult to demonstrate the effects of indomethacin on energy charge in vivo. In addition, the problem of relating in vitro inhibition and in vivo effects is highlighted. The observation that indomethacin was found to perturb energy metabolism in vitro [8] is not sufficient evidence that similar effects occur in vivo, for a variety of reasons. The compositions of in vitro incubation mixtures vary much more widely than those present in the cells of the body. The relative proportions of enzymes, substrates, cofactors, the pH and ionic constituents of the incubation media may bear little resemblance to physiological requirements [16] . The concentration of a drug in vivo may vary with both tissue and time in the body, whereas in vitro it will remain relatively constant. It is not possible to predict accurately the tissue concentration of a drug from a knowledge of the exact size of the ingested dose, since, in individual animals or subjects, factors such as absorption from the gut and subsequent distribution among the various body fluids, organs and tissues vary widely [16] .
A direct demonstration of an uncoupling or inhibitory action of indomethacin in the whole animal, in terms of its effects on energy metabolism, may therefore be difficult to accomplish. Studies have shown that administration of NSAIDs, such as aspirin and sodium salicylate, did not decrease either the normal ATP concentration in the liver and paw, or the elevated ATP concentrations in oedematous paws, in rats [17] [18] [19] . On the other hand, some studies have shown the opposite effect on energy metabolism. Jorgensen et al. [20] and Arvanitakis et al. [21] measured falls in ATP levels in pig gastric mucosa and human jejunal biopsies respectively after ingestion of aspirin. However, the doses used in these studies were very high, 10 g in the former and 2n6 g in the latter, both administered as a single dose. These large doses are probably responsible for the effects seen on ATP levels when measurements were made ex vivo.
The most probable explanation for the lack of effect of indomethacin in vivo is that, unlike isolated mitochondria and jejunal tissue in vitro, the whole animal seems to be able to maintain ATP levels in the presence of NSAIDs such as indomethacin and aspirin (at pharmacological doses). Greater amounts of substrate can be sacrificed to supply energy and to maintain energy levels. In addition, ATP may be formed by anaerobic phosphorylation reactions at the substrate level, which are not affected by these drugs. This has been demonstrated in an in vitro system by Kalbhen and Domenjoz [18] . They showed that when neoplastic mast cells, which rely on glycolysis for most of their energy production, are incubated with salicylate, the level of ATP increases, although the efficiency of ATP production by the respiratory chain is reduced. The present study also documented an increased rate of glycolysis in indomethacin-treated tissue. It must also be kept in mind that most NSAIDs are proteinbound in the circulation ( 95 %), and there may be insufficient levels of free drug to exert uncoupling effects. Another possible explanation for the lack of effect of indomethacin in vivo is the occurrence of proton leak in oxygen-consuming tissues of the rat [22, 23] . Proton leak is responsible for a significant proportion of total oxygen uptake by the tissue. It could thus account for the observation that no changes occurred in energy charge in vivo, as the mitochondria may be already partially uncoupled in vivo. Effects of indomethacin on mitochondrial function in vivo and ex vivo are difficult to demonstrate. Thus it may not be possible to detect small degrees of impairment of mitochondrial function that may, nevertheless, be detrimental to the tissue.
In conclusion, only minor changes in intestinal energy levels occur after indomethacin dosing in vivo. Recent advances have increased our understanding of mechanisms of cell death and how these relate to energy metabolism and mitochondrial function [24] . In particular, it has been shown that small decreases in cellular ATP levels are associated with apopotic cell death, if accompanied by appropriate triggers. Mitochondrial damage has been shown to be a trigger for apopotis [24] . This information, combined with previous evidence for mitochondrial uncoupling in vivo [6] , suggests that indomethacin does not induce conditions likely to produce widespread necrotic cell death ; however, apoptosis may be triggered by the mitochondrial damage [25] . ACKNOWLEDGMENTS M. J. was supported by a Cowburn studentship from King's College School of Medicine.
